Expert Opinion on Drug Delivery
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.0 | Q1 | 87.4% | 1.057 | Q1 | 85.3% |
| 2024 | 5.4 | Q1 | 89.5% | 1.053 | Q1 | 85.5% |
| 2023 | 5.0 | Q1 | 88.2% | 1.009 | Q1 | 85.7% |
| 2022 | 6.6 | Q1 | 91.4% | 1.018 | Q1 | 86.6% |
| 2021 | 8.1 | Q1 | 94.1% | 1.064 | Q1 | 87.8% |
| 2020 | — | — | 1.084 | Q1 | 87.0% | |
| 2019 | — | — | 1.001 | Q1 | 85.6% | |
| 2018 | — | — | 1.337 | Q1 | 90.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-7593
ISSN
1742-5247
region
Western Europe
coverage
2004-2026